tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Cybin Advances Clinical Programs in Psychedelic Therapeutics
Company AnnouncementsCybin Advances Clinical Programs in Psychedelic Therapeutics
17d ago
CYBN
Cybin Inc. Strengthens U.S. Market Position with New SEC Filing
PremiumCompany Announcements
Cybin Inc. Strengthens U.S. Market Position with New SEC Filing
22d ago
6K
CYBN
Cybin Inc. Announces CEO Transition as of September 2, 2025
PremiumCompany Announcements
Cybin Inc. Announces CEO Transition as of September 2, 2025
23d ago
6K
CYBN
Cybin’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating
PremiumRatings
Cybin’s Promising Clinical Advancements and Strategic Positioning Justify Buy Rating
28d ago
CYBN
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
PremiumThe Fly
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
29d ago
CYBN
DRUG
Cybin to Engage in TD Cowen’s Neuropsychiatry Summit
PremiumCompany AnnouncementsCybin to Engage in TD Cowen’s Neuropsychiatry Summit
29d ago
CYBN
Cybin Completes Enrollment in Phase 2 Study for GAD Treatment
Premium
Company Announcements
Cybin Completes Enrollment in Phase 2 Study for GAD Treatment
1M ago
CYBN
Cybin completes enrollment in CYB004 study
Premium
The Fly
Cybin completes enrollment in CYB004 study
1M ago
CYBN
Psychedelic: Bright Minds reports preclinical BMB-201 results
PremiumThe Fly
Psychedelic: Bright Minds reports preclinical BMB-201 results
1M ago
CMPS
CYBN
Cybin to Engage at H.C. Wainwright Investment Conference
PremiumCompany Announcements
Cybin to Engage at H.C. Wainwright Investment Conference
1M ago
CYBN
Cybin to Engage at Cantor Global Healthcare Conference 2025
PremiumCompany Announcements
Cybin to Engage at Cantor Global Healthcare Conference 2025
1M ago
CYBN
Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint
PremiumThe Fly
Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint
1M ago
NIO
PEP
Cybin Announces Leadership Transition with Eric So as Interim CEO
PremiumCompany AnnouncementsCybin Announces Leadership Transition with Eric So as Interim CEO
1M ago
CYBN
Cybin CEO Doug Drysdale steps down
Premium
The Fly
Cybin CEO Doug Drysdale steps down
1M ago
CYBN
Psychedelic: Exclusive talk with biopharma company Reunion Neuroscience
Premium
The Fly
Psychedelic: Exclusive talk with biopharma company Reunion Neuroscience
1M ago
ATAI
CMND
Cybin Gains Australian Approval for EMBRACE Study in Major Depressive Disorder
PremiumCompany Announcements
Cybin Gains Australian Approval for EMBRACE Study in Major Depressive Disorder
2M ago
CYBN
Cybin receives Australian approval for EMBRACE study
PremiumThe Fly
Cybin receives Australian approval for EMBRACE study
2M ago
CYBN
Cybin Announces Shareholder Meeting Results and Strategic Developments
PremiumCompany Announcements
Cybin Announces Shareholder Meeting Results and Strategic Developments
2M ago
CYBN
Cybin’s Strategic Advancements and Financial Positioning Drive Buy Rating
PremiumRatings
Cybin’s Strategic Advancements and Financial Positioning Drive Buy Rating
2M ago
CYBN
Psychedelic: atai Life Sciences, Cybin report earnings results
PremiumThe FlyPsychedelic: atai Life Sciences, Cybin report earnings results
2M ago
ATAI
CYBN
Cybin’s Promising Pipeline and Upcoming Milestones Justify Buy Rating
Premium
Ratings
Cybin’s Promising Pipeline and Upcoming Milestones Justify Buy Rating
2M ago
CYBN
Cybin Inc. Reports Q2 2025 Financial Results with Asset Growth
Premium
Company Announcements
Cybin Inc. Reports Q2 2025 Financial Results with Asset Growth
2M ago
6K
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >